Depression in the medically ill elderly: A focus on methylphenidate

Annals of Pharmacotherapy

Volumn 30, Issue 2, 1996, Pages 151-157

  Emptage, Ruth E ^a,b   Semla, Todd P ^c,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c St Francis Hospital   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; NORTRIPTYLINE;

AGED; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030059253     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000209     Document Type: Review

References (43)

1. Weissman MM, Leaf FJ, Tischler GL, Blazer DG, Karno M, Bruce ML, et al. Affective disorders in five United States communities. Psychol Med 1988;18:141-53.
2. Koenig HG, Meador KG, Shelp F, Goli V, Cohen HJ, Blazer DG. Major depressive disorder in hospitalized medically ill patients: an examination of young and elderly male veterans. J Am Geriatr Soc 1991;39:881-90.
3. Rapp SR, Parisi SA, Walsh DA. Psychological dysfunction and physical health among elderly medical inpatients. J Consult Clin Psychol 1988;56:851-5.
4. Koenig HG, Blazer DG. Epidemiology of geriatric affective disorders. Clin Geriatr Med 1992,8:235-51.
5. Feibel JH, Springer CJ. Depression and failure to resume social activities after stroke. Arch Phys Med Rehabil 1982;63:276-8.
6. Sinyor D, Jacques P, Kaloupek DG, Becker R, Golenberg M, Coopersmith H. Poststroke depression and lesion location: an attempted replication. Brain 1986;109:537-46.
7. House A, Dennis M, Warlow C, Hawton K, Molyneux A. Mood disorders after stroke and their relation to lesion location. Brain 1990;113:1113-29.
8. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke 1987;18:837-43.
9. Rapp SR, Walsh DA, Parisi SA, Wallace CE Detecting depression in elderly medical inpatients. J Consult Clin Psychol 1988;56:509-13.
10. Koenig HG, Blazer DG, Ford SM. Should physicians screen for depression in elderly medical inpatients? Results of a decision analysis. Int J Psychiatry Med 1993;23:211-35.
11. Koenig HG, Cohen HJ, Blazer DG, Krishnan KRR, Sibert TE. Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993;41:1169-76.
12. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
13. Schwab JJ, Bialow M, Brown JM. Diagnosing depression in medical inpatients. Ann Intern Med 1967;67:695-707.
14. Stewart JA, Drake F, Winokur G. Depression among medically ill patients. Dis Nerv Syst 1965;26:479-85.
15. Mossey J, Knott K, Craik R. The effects of persistent depressive symptoms on hip fracture recovery. J Gerontol 1990;45:M163-8.
16. Parikh R, Robinson R, Lipsey J, Starkstein SE, Fedoroff JP, Price TR The impact of poststroke depression on recovery in activities of daily living over a 2 year follow-up. Arch Neurol 1990,47:785-9.
17. Stoudemire A, Thompson TL. Medication noncompliance: systematic approaches to evaluation and intervention. Gen Hosp Psychiatry 1983;5:233-9.
18. Koenig HG, Shelp F, Goli V, Cohen HJ, Blazer DG. Survival and health care utilization in elderly medical inpatients with major depression. J Am Geriatr Soc 1989;37:599-606.
19. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-9.
20. Mendels J. Clinical management of the depressed geriatric patient: current therapeutic options. Am J Med 1993;94(suppl 5A):13S-8S.
21. Alexopoulos GS. Treatment of depression. In: Salzman C, ed. Clinical geriatric psychopharmacology. 2nd ed. Baltimore: Williams and Wilkins, 1992:137-74.
22. Stimmel GL, Guitierrz MA. Psychiatric disorders. In: Delafuente JC, Stewart RB, eds. Therapeutics in the elderly. 2nd ed. Cincinnati, OH: Harvey Whitney Books, 1995:324-43.
23. Tatro DS, Olin BR, Hebel SK, eds. Drug interaction facts. St Louis: Facts and Comparisons, 1995.
24. Chiarello RJ, Cole JO. The use of psychostimulants in general psychiatry. Arch Gen Psychiatry 1987;44:286-95.
25. Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DC, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995:923-4.
26. Hoffman BB, Lefkowitz RJ. Catecholammes and sympathomimetic drugs. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Permagon Press, 1990:187-220.
27. Askinazi C, Weintraub RJ, Karamouz N. Elderly depressed females as a possible subgroup of patients responsive to methylphenidate. J Clin Psychiatry 1986;47:467-9.
28. Lingam VR, Lazarus LW, Groves L, Oh SH. Methylphenidate in treating poststroke depression. J Clin Psychiatry 1988;49:151-3.
29. Johnson ML, Roberts MD, Ross AR, Witten CM. Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992;71:239-41.
30. Pickett P, Masand P, Murray GB. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness. J Geriatr Psychiatry Neurol 1990;3:146-51.
31. Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975;23:271-6.
32. Larsson M, Ervik M, Lundborg P, Sundh V, Svanborg A. Comparison between methylphenidate and placebo as adjuvant in care and rehabilitation of geriatric patient. Compr Gerontol A 1988;2:53-9.
33. Lazarus LW, Winemiller DR, Lingam VR, Neyman I, Hartman C, Abassian M, et al. Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry 1992;53:447-9.
34. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995;152:929-31.
35. Lazarus LW, Moberg PJ, Langsley PR, Lingam VR. Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison. Arch Phys Med Rehabil 1994;75:403-6.
36. Gerson SC, Plotkin DA, Jarvik LF. Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. J Clin Psychopharmacol 1988;8:311-22.
37. Drug facts and comparisons. St. Louis: Facts and Comparisons, 1995:1488-90.
38. Frierson RL, Wey JJ, Tabler JB. Psychostimulants for depression in the medically ill. Am Fam Phys 1991;43:163-70.
39. Gurian B, Rosowsky E. Low-dose methylphenidate in the very old. J Geriatr Psychiatry Neurol 1990;3:152-4.
40. Katon W, Raskind M. Treatment of depression in the medically ill elderly with methylphenidate. Am J Psychiatry 1980,137:963-5.
41. Kraus MF, Burch EA. Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review. South Med J 1992;85:985-91.
42. Warton RN, Perel JM, Dayton PG, Malitz S. A potential clinical use for methylphenidate with tricyclic antidepressants. Am J Psychiatry 1971;127:1619-25.
43. Grimsley SR, Jann MW. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharm 1992;11:930-57.